Literature DB >> 34044806

Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.

Chao Wu1, Sheng Zhong Hou1, Zuowei Wu1, Xing Huang1, Zihe Wang1, Bole Tian2.   

Abstract

BACKGROUND: Radical pancreaticoduodenectomy is the most common treatment strategy for patients diagnosed with adenocarcinoma of the pancreatic head. Few studies have reported the clinical characteristics and treatment efficacies of patients undergoing radical pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
METHODS: A total of 177 pancreatic head cancer patients who underwent radical pancreaticoduodenectomy and were pathologically confirmed as having pancreatic ductal adenocarcinoma were screened in the West China Hospital of Sichuan University. The multivariate analysis results were implemented to construct a nomogram. The concordance index (c-index), the area under the curve (AUC) and calibration were utilized to evaluate the predictive performance of the nomogram.
RESULTS: The prognostic nutritional index (PNI), the lymph node ratio (LNR) and the American Joint Committee on Cancer (AJCC) staging served as independent prognostic factors and were used to construct the nomogram. The c-indexes of the nomogram were 0.799 (confidence interval (CI), 0.741-0.858) and 0.732 (0.657-0.807) in the primary set and validation set, respectively. The AUCs of the nomogram at 1 and 3 years were 0.832 and 0.783, which were superior to the AJCC staging values of 0.759 and 0.705, respectively.
CONCLUSIONS: The nomogram may be used to predict the prognosis of radical resection for adenocarcinoma of the pancreatic head. These findings may represent an effective model for the developing an optimal therapeutic schedule for malnourished patients who need early effective nutritional intervention and may promote the treatment efficacy of resectable adenocarcinoma of the pancreatic head.

Entities:  

Keywords:  Adenocarcinoma of the pancreatic head; Nomogram; Pancreaticoduodenectomy; Prognostic

Year:  2021        PMID: 34044806     DOI: 10.1186/s12885-021-08295-5

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  30 in total

1.  Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.

Authors:  Marco La Torre; Giuseppe Nigri; Niccolò Petrucciani; Marco Cavallini; Paolo Aurello; Giulia Cosenza; Genoveffa Balducci; Vincenzo Ziparo; Giovanni Ramacciato
Journal:  Pancreatology       Date:  2014-06-14       Impact factor: 3.996

2.  Nutritional predictors of postoperative outcome in pancreatic cancer.

Authors:  M Kanda; T Fujii; Y Kodera; S Nagai; S Takeda; A Nakao
Journal:  Br J Surg       Date:  2011-02       Impact factor: 6.939

Review 3.  A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma.

Authors:  M Elshaer; G Gravante; M Kosmin; A Riaz; A Al-Bahrani
Journal:  Ann R Coll Surg Engl       Date:  2016-11-21       Impact factor: 1.891

4.  [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients].

Authors:  T Onodera; N Goseki; G Kosaki
Journal:  Nihon Geka Gakkai Zasshi       Date:  1984-09

5.  Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification.

Authors:  Daishi Morimoto; Suguru Yamada; Kenta Murotani; Fuminori Sonohara; Hideki Takami; Masaya Suenaga; Masamichi Hayashi; Yukiko Niwa; Mitsuru Tashiro; Norifumi Hattori; Naoki Iwata; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Goro Nakayama; Masahiko Koike; Michitaka Fujiwara; Tsutomu Fujii; Yasuhiro Kodera
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

6.  Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging?

Authors:  Nabil Wasif; Clifford Y Ko; James Farrell; Zev Wainberg; Oscar J Hines; Howard Reber; James S Tomlinson
Journal:  Ann Surg Oncol       Date:  2010-04-27       Impact factor: 5.344

7.  The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer.

Authors:  Sang Hoon Lee; Moon Jae Chung; Bun Kim; Hee Seung Lee; Hyun Jik Lee; Ja Yoon Heo; Yeong Jin Kim; Jeong Youp Park; Seungmin Bang; Seung Woo Park; Si Young Song; Jae Bock Chung
Journal:  Nutr Cancer       Date:  2016-12-14       Impact factor: 2.900

Review 8.  Pancreatic cancer.

Authors:  Terumi Kamisawa; Laura D Wood; Takao Itoi; Kyoichi Takaori
Journal:  Lancet       Date:  2016-01-30       Impact factor: 79.321

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 10.  Optimizing the outcomes of pancreatic cancer surgery.

Authors:  Oliver Strobel; John Neoptolemos; Dirk Jäger; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2019-01       Impact factor: 66.675

View more
  3 in total

1.  Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.

Authors:  Zhenjiang Guo; Honghai Guo; Yuan Tian; Ze Zhang; Qun Zhao
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

2.  Clinical Analysis of C-Shaped Embedded Pancreaticojejunostomy in Pancreaticoduodenectomy.

Authors:  Hui Huang; Jichun Sun; Zhiqiang Li; Longjun Zang; Hongwei Zhu; Xianlin Zhang; Xiao Yu
Journal:  J Oncol       Date:  2022-05-27       Impact factor: 4.501

3.  Lymph node ratio is a superior predictor in surgically treated early-onset pancreatic cancer.

Authors:  Yangyang Zheng; Zhenhua Lu; Xiaolei Shi; Tianhua Tan; Cheng Xing; Jingyong Xu; Hongyuan Cui; Jinghai Song
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.